4//SEC Filing
CORRIGAN MARK 4
Accession 0001104659-21-077205
CIK 0001641640other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 5:50 PM ET
Size
5.4 KB
Accession
0001104659-21-077205
Insider Transaction Report
Form 4
CORRIGAN MARK
Director
Transactions
- Award
Share Options
2021-06-02+10,500→ 10,500 totalExercise: $1.39Exp: 2031-06-01→ Ordinary Shares (10,500 underlying)
Footnotes (2)
- [F1]The option was granted on June 2, 2021.
- [F2]The option will vest over a three-year period on a monthly pro rata basis beginning on June 2, 2021 and subject to the Reporting Person's continued service on the board of directors of the Issuer.
Documents
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeother
Related Parties
1- filerCIK 0001250661
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 5:50 PM ET
- Size
- 5.4 KB